An Open-Label Study of the Safety and Efficacy of Atiprimod Treatment for Patients With Advanced Cancer

AZD6244 (ARRY-142886) Solid Oral Dosage Formulation in Participants With Advanced Solid Malignancies

NCT00463814 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Study of AS1411 in Advanced Solid Tumours

NCT00881244 ·Status: COMPLETED ·Phase: PHASE1

A Dose Escalation and Expansion Study of ASP4132 to Subjects With Advanced Refractory Tumors and Lymphoma

NCT02383368 ·Status: COMPLETED ·Phase: PHASE1

Study Of ATRN-119 In Patients With Advanced Solid Tumors

NCT04905914 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies

NCT04644068 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Study of APR-1051 in Patients With Advanced Solid Tumors

NCT06260514 ·Status: RECRUITING ·Phase: PHASE1

The Effects of AZD2171 in Patients With Non-Small Cell Lung Cancer or Head & Neck Cancer

NCT00243347 ·Status: COMPLETED ·Phase: PHASE1

Study to Assess the Safety of Escalating Doses of AT13387 in Patients With Metastatic Solid Tumors

NCT00878423 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess Safety, Tolerability and PK of AZD2171 and Chemotherapy on Patients With Solid Tumors

NCT00502567 ·Status: COMPLETED ·Phase: PHASE1

First-in-human Study of AB0024 to Evaluate Safety and Tolerability in Adults With Advanced Solid Tumors

NCT01323933 ·Status: COMPLETED ·Phase: PHASE1

SMP-3124LP in Adults With Advanced Solid Tumors

NCT06526819 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Phase I AZD2281/Cisplatin in Advanced Solid Tumour Patients

NCT00782574 ·Status: COMPLETED ·Phase: PHASE1

An Open-Label, Dose-Escalation Study of AZD2461

NCT01247168 ·Status: COMPLETED ·Phase: PHASE1

Safety and Tolerability Study of AZD2171 in Combination With AZD0530 in Patients With Advanced Solid Tumours

NCT00475956 ·Status: COMPLETED ·Phase: PHASE1

Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors

NCT04771520 ·Status: RECRUITING ·Phase: PHASE2

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

NCT04657068 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors

NCT06533059 ·Status: RECRUITING ·Phase: PHASE1

Phase I Study of AZD2171 co-Administered With Fixed Multiple Oral Doses of ZD1839 in Patients With Advanced Cancer

NCT00502060 ·Status: COMPLETED ·Phase: PHASE1

GLPG0187: Safety, Tolerability and Pharmacokinetics in Patients With Solid Tumors

NCT01313598 ·Status: COMPLETED ·Phase: PHASE1

A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors

NCT02498613 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Study to Assess the Safety and Preliminary Efficacy of AZD0156 at Increasing Doses Alone or in Combination With Other Anti-cancer Treatment in Patients With Advanced Cancer

NCT02588105 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerability and Maximum Tolerated Dose of Oral AP23573 in Combination With Doxorubicin (8669-015)

NCT00288431 ·Status: COMPLETED ·Phase: PHASE1

Ph. 1, Evaluation of Safety, Tolerability, PK, Anti-tumor Activity of STP707 IV in Subjects With Solid Tumors

NCT05037149 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmocodynamics and Preliminary Antitumor Activity of AT-1965 in Patients With Advanced, Refractory or Recurrent Solid Tumors

NCT06234098 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Study to Determine and Evaluate a Safe and Tolerated Dose of HDM201 in Patients With Selected Advanced Tumors That Are TP53wt

NCT02143635 ·Status: COMPLETED ·Phase: PHASE1